Sign In
Buy EDIT
Editas Medicine Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be positive at 65.24. In total, the insiders bought 6.36M and sold 211.57K EDIT shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
65.24 |
| ● Buy | 6.36M shares |
| ● Sell | 211.57K shares |
|
51% Buy Activity
Negligible or No Correlation
|
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Mar 04, 2025 Sell |
O'neill Gilmore Neil CEO |
16 632 Value: $28.5K |
||
|
Mar 04, 2025 Sell |
Lucera Erick EVP, Chief Financial Officer |
4 109 Value: $7K |
||
|
Dec 03, 2024 Sell |
O'neill Gilmore Neil CEO |
1 618 Value: $3K |
||
|
Dec 03, 2024 Sell |
Mei Baisong EVP, Chief Medical Officer |
541 Value: $1K |
||
|
Dec 03, 2024 Sell |
Mei Baisong EVP, Chief Medical Officer |
541 Value: $1K |
||
|
Dec 03, 2024 Sell |
O'neill Gilmore Neil CEO |
1 618 Value: $3K |
||
|
Sep 04, 2024 Sell |
Mei Baisong EVP, Chief Medical Officer |
518 Value: $2K |
||
|
Sep 04, 2024 Sell |
O'neill Gilmore Neil CEO |
1 555 Value: $5K |
||
|
Sep 04, 2024 Sell |
O'neill Gilmore Neil CEO |
1 555 Value: $5K |
||
|
Sep 04, 2024 Sell |
Mei Baisong EVP, Chief Medical Officer |
518 Value: $2K |
||
|
Jul 25, 2024 Sell |
Burkly Linda EVP, Chief Scientific Officer |
11 886 Value: $64.4K |
||
|
Jul 25, 2024 Sell |
Burkly Linda EVP, Chief Scientific Officer |
11 886 Value: $64.4K |
||
|
Jul 19, 2024 Sell |
Mei Baisong EVP, Chief Medical Officer |
6 619 Value: $34.5K |
||
|
Jul 19, 2024 Sell |
Mei Baisong EVP, Chief Medical Officer |
6 619 Value: $34.5K |
||
|
Jun 04, 2024 Sell |
O'neill Gilmore Neil CEO |
12 191 Value: $67.0K |
||
|
Jun 04, 2024 Sell |
Mei Baisong EVP, Chief Medical Officer |
511 Value: $3K |
||
|
Jun 04, 2024 Sell |
Mei Baisong EVP, Chief Medical Officer |
511 Value: $3K |
||
|
Jun 04, 2024 Sell |
O'neill Gilmore Neil CEO |
12 191 Value: $67.0K |
||
|
May 30, 2024 Buy |
Scadden David Director |
25 000 Value: $129.3K |
||
|
May 30, 2024 Buy |
Hopfield Jessica Director |
25 000 Value: $129.3K |
||
|
May 30, 2024 Buy |
Chatterjee Meeta Director |
25 000 Value: $129.3K |
||
|
May 30, 2024 Buy |
Hirsch Andrew Director |
25 000 Value: $129.3K |
||
|
May 30, 2024 Buy |
Reeve Emma Director |
25 000 Value: $129.3K |
||
|
May 30, 2024 Buy |
Levy Elliott M. Director |
25 000 Value: $129.3K |
||
|
May 30, 2024 Buy |
Connaughton Bernadette Director |
25 000 Value: $129.3K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
